An epidemiological survey of Raynaud's phenomenon
A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the asso...
Gespeichert in:
Veröffentlicht in: | European journal of vascular surgery 1988-06, Vol.2 (3), p.167-170 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 170 |
---|---|
container_issue | 3 |
container_start_page | 167 |
container_title | European journal of vascular surgery |
container_volume | 2 |
creator | de Trafford, J.C. Lafferty, K. Potter, C.E. Roberts, V.C. Cotton, L.T. |
description | A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P < 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age < 30, 14% > 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P < 0.01), angina (3% higher P < 0.05) and duodenal ulcer (3% higher P < 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years (
s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years (
s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions. |
doi_str_mv | 10.1016/S0950-821X(88)80070-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78376029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0950821X88800707</els_id><sourcerecordid>78376029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</originalsourceid><addsrcrecordid>eNqFkMlqwzAQhnVoSdO0jxDwqcvB7ci2LPlUQugGgUIX6E3I0rhVsS1XigN5-zoLuXZgGJjtn_kImVK4oUDz2zcoGMQioZ9XQlwLAA4xPyLjQ_qEnIbwA5DyApIRGaUZBcjZmNBZG2FnDTbW1e7LalVHofcrXEeuil7VulW9uQxR942tawZvz8hxpeqA5_s4IR8P9-_zp3jx8vg8ny1inXC2jEtTVSBMWQ4n8HwwzaqUJVRAUmpQghYCKxSFMYalDLOiTCpOIcsYqDRTJp2Qi93ezrvfHsNSNjZorGvVouuD5CLlOSTF0Mh2jdq7EDxWsvO2UX4tKcgNHrnFIzccpBByi0fyYW66F-jLBs1has9mqN_t6jh8ubLoZdAWW43GetRLaZz9R-EPHVh2Rw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78376029</pqid></control><display><type>article</type><title>An epidemiological survey of Raynaud's phenomenon</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</creator><creatorcontrib>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</creatorcontrib><description>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P < 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age < 30, 14% > 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P < 0.01), angina (3% higher P < 0.05) and duodenal ulcer (3% higher P < 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years (
s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years (
s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</description><identifier>ISSN: 0950-821X</identifier><identifier>DOI: 10.1016/S0950-821X(88)80070-7</identifier><identifier>PMID: 3410065</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Angina Pectoris - epidemiology ; Child ; Epidemiology ; Female ; Fetal Death - complications ; Health Surveys ; Humans ; Infertility - epidemiology ; Male ; Menopause ; Menstrual Cycle ; Middle Aged ; Migraine Disorders - epidemiology ; Pre-Eclampsia - epidemiology ; Pregnancy ; Raynaud Disease - complications ; Raynaud Disease - epidemiology ; Raynaud Disease - therapy ; Raynaud's phenomenon ; Scleroderma ; Scleroderma, Systemic - complications ; Surveys and Questionnaires ; Sympathectomy</subject><ispartof>European journal of vascular surgery, 1988-06, Vol.2 (3), p.167-170</ispartof><rights>1988 Grune & Stratton Ltd</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</citedby><cites>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3410065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Trafford, J.C.</creatorcontrib><creatorcontrib>Lafferty, K.</creatorcontrib><creatorcontrib>Potter, C.E.</creatorcontrib><creatorcontrib>Roberts, V.C.</creatorcontrib><creatorcontrib>Cotton, L.T.</creatorcontrib><title>An epidemiological survey of Raynaud's phenomenon</title><title>European journal of vascular surgery</title><addtitle>Eur J Vasc Surg</addtitle><description>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P < 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age < 30, 14% > 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P < 0.01), angina (3% higher P < 0.05) and duodenal ulcer (3% higher P < 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years (
s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years (
s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angina Pectoris - epidemiology</subject><subject>Child</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fetal Death - complications</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Infertility - epidemiology</subject><subject>Male</subject><subject>Menopause</subject><subject>Menstrual Cycle</subject><subject>Middle Aged</subject><subject>Migraine Disorders - epidemiology</subject><subject>Pre-Eclampsia - epidemiology</subject><subject>Pregnancy</subject><subject>Raynaud Disease - complications</subject><subject>Raynaud Disease - epidemiology</subject><subject>Raynaud Disease - therapy</subject><subject>Raynaud's phenomenon</subject><subject>Scleroderma</subject><subject>Scleroderma, Systemic - complications</subject><subject>Surveys and Questionnaires</subject><subject>Sympathectomy</subject><issn>0950-821X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlqwzAQhnVoSdO0jxDwqcvB7ci2LPlUQugGgUIX6E3I0rhVsS1XigN5-zoLuXZgGJjtn_kImVK4oUDz2zcoGMQioZ9XQlwLAA4xPyLjQ_qEnIbwA5DyApIRGaUZBcjZmNBZG2FnDTbW1e7LalVHofcrXEeuil7VulW9uQxR942tawZvz8hxpeqA5_s4IR8P9-_zp3jx8vg8ny1inXC2jEtTVSBMWQ4n8HwwzaqUJVRAUmpQghYCKxSFMYalDLOiTCpOIcsYqDRTJp2Qi93ezrvfHsNSNjZorGvVouuD5CLlOSTF0Mh2jdq7EDxWsvO2UX4tKcgNHrnFIzccpBByi0fyYW66F-jLBs1has9mqN_t6jh8ubLoZdAWW43GetRLaZz9R-EPHVh2Rw</recordid><startdate>198806</startdate><enddate>198806</enddate><creator>de Trafford, J.C.</creator><creator>Lafferty, K.</creator><creator>Potter, C.E.</creator><creator>Roberts, V.C.</creator><creator>Cotton, L.T.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198806</creationdate><title>An epidemiological survey of Raynaud's phenomenon</title><author>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angina Pectoris - epidemiology</topic><topic>Child</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fetal Death - complications</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Infertility - epidemiology</topic><topic>Male</topic><topic>Menopause</topic><topic>Menstrual Cycle</topic><topic>Middle Aged</topic><topic>Migraine Disorders - epidemiology</topic><topic>Pre-Eclampsia - epidemiology</topic><topic>Pregnancy</topic><topic>Raynaud Disease - complications</topic><topic>Raynaud Disease - epidemiology</topic><topic>Raynaud Disease - therapy</topic><topic>Raynaud's phenomenon</topic><topic>Scleroderma</topic><topic>Scleroderma, Systemic - complications</topic><topic>Surveys and Questionnaires</topic><topic>Sympathectomy</topic><toplevel>online_resources</toplevel><creatorcontrib>de Trafford, J.C.</creatorcontrib><creatorcontrib>Lafferty, K.</creatorcontrib><creatorcontrib>Potter, C.E.</creatorcontrib><creatorcontrib>Roberts, V.C.</creatorcontrib><creatorcontrib>Cotton, L.T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Trafford, J.C.</au><au>Lafferty, K.</au><au>Potter, C.E.</au><au>Roberts, V.C.</au><au>Cotton, L.T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An epidemiological survey of Raynaud's phenomenon</atitle><jtitle>European journal of vascular surgery</jtitle><addtitle>Eur J Vasc Surg</addtitle><date>1988-06</date><risdate>1988</risdate><volume>2</volume><issue>3</issue><spage>167</spage><epage>170</epage><pages>167-170</pages><issn>0950-821X</issn><abstract>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P < 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age < 30, 14% > 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P < 0.01), angina (3% higher P < 0.05) and duodenal ulcer (3% higher P < 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years (
s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years (
s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>3410065</pmid><doi>10.1016/S0950-821X(88)80070-7</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-821X |
ispartof | European journal of vascular surgery, 1988-06, Vol.2 (3), p.167-170 |
issn | 0950-821X |
language | eng |
recordid | cdi_proquest_miscellaneous_78376029 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Adult Age Factors Aged Aged, 80 and over Angina Pectoris - epidemiology Child Epidemiology Female Fetal Death - complications Health Surveys Humans Infertility - epidemiology Male Menopause Menstrual Cycle Middle Aged Migraine Disorders - epidemiology Pre-Eclampsia - epidemiology Pregnancy Raynaud Disease - complications Raynaud Disease - epidemiology Raynaud Disease - therapy Raynaud's phenomenon Scleroderma Scleroderma, Systemic - complications Surveys and Questionnaires Sympathectomy |
title | An epidemiological survey of Raynaud's phenomenon |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A15%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20epidemiological%20survey%20of%20Raynaud's%20phenomenon&rft.jtitle=European%20journal%20of%20vascular%20surgery&rft.au=de%20Trafford,%20J.C.&rft.date=1988-06&rft.volume=2&rft.issue=3&rft.spage=167&rft.epage=170&rft.pages=167-170&rft.issn=0950-821X&rft_id=info:doi/10.1016/S0950-821X(88)80070-7&rft_dat=%3Cproquest_cross%3E78376029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78376029&rft_id=info:pmid/3410065&rft_els_id=S0950821X88800707&rfr_iscdi=true |